Inventor
MCDANIEL KEITH F
US26 patents
⚠️ This page may combine multiple inventors who share the name “MCDANIEL KEITH F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE INC
11 patentsUS10085985B2Oct 2, 2018
Bromodomain inhibitors
ABBVIE INC2 citations73
US9493411B2Nov 15, 2016
Pyrrole-3-carboxamide bromodomain inhibitors
ABBVIE INC3 citations72
US9321764B2Apr 26, 2016
Dihydro-pyrrolopyridinone inhibitors
ABBVIE INC3 citations72
US9296741B2Mar 29, 2016
Bromodomain inhibitors
ABBVIE INC7 citations72
US9050346B2Jun 9, 2015
Bromodomain inhibitors
ABBVIE INC5 citations72
US10633379B2Apr 28, 2020
Bromodomain inhibitors
ABBVIE INC4 citations71
US9561231B2Feb 7, 2017
Pyridinone and pyridazinone derivatives
ABBVIE INC4 citations71
US10035800B2Jul 31, 2018
Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors
ABBVIE INC3 citations70
US9994581B2Jun 12, 2018
Bromodomain inhibitors
ABBVIE INC2 citations62
US9428514B2Aug 30, 2016
Bromodomain inhibitors
ABBVIE INC1 citations52
US9309279B2Apr 12, 2016
Macrocyclic hepatitis C serine protease inhibitors
ABBVIE INC0 citations49
ABBOTT LAB
7 patentsUS6455571B1Sep 24, 2002
Inhibitors of neuraminidases
ABBOTT LAB60 citations95
US7910595B2Mar 22, 2011
Anti-viral compounds
ABBOTT LAB18 citations83
US7378414B2May 27, 2008
Anti-infective agents
ABBOTT LAB17 citations82
US7915411B2Mar 29, 2011
Anti-viral compounds
ABBOTT LAB3 citations61
US6831096B2Dec 14, 2004
Inhibitors of neuraminidases
ABBOTT LAB3 citations61
US7538105B2May 26, 2009
Anti-infective agents
ABBOTT LAB0 citations50
US7902203B2Mar 8, 2011
Anti-infective agents
ABBOTT LAB0 citations39